| ||||
Last Loaded on Web: Monday, December 01, 2008
| ||||
Last Loaded on Web: Monday, December 01, 2008
| Database Description |
| Subject Coverage |
| Dialog File Data |
| Contact |
| Terms and Conditions |
IMS R&D Focus is a powerful tool to evaluate the progress of R&D pipelines from Discovery phase to Marketed phase. With more than 23,300 drugs in R&D, 9,400 drugs in active development, and 4,800 biotechnology products, the file provides the latest scientific and commercial developments in international pharmaceutical research and development. All aspects of a drug's development are presented in a convenient "all in one" record format. More than 3,000 companies are profiled with respect to their involvement in the development of a drug as well as their relationships as licensor and licensee. Full commercial summaries provide a commercial overview, regulatory progress, licensing and partnering deals, and analysts' sales predictions.
The file corresponds to the electronic publication R&D Focus (Drug Profile records) and incorporates R&D Focus Drug News, the weekly news service that reports on more than 23,000 drugs compiled by editors via interviews at scientific and investor conferences worldwide. These records cover new drugs in research, changes in development phases, and licensing opportunities. File 445 is publicly available; File 955 is available only to subscribers of R&D Focus and R&D Drug News. Images of chemical structures are available for more than 6,000 Drug Profile records.
IMS R&D Focus provides comprehensive reviews and up-to-date news on drugs in development including full synonyms, licensing status, patent summary, development history, commercial potential, scientific and commercial summaries, and abstracts of significant scientific papers. Scientific summaries detail pre-clinical and clincial data and sales profiles of 123 leading therapeutic classes using IMS sales data. Some financial background of the disease area is provided when available.
| Dates Covered: | 1991 to the present, covering drugs in development since 1977 |
|---|---|
| File Size: | More than 84,200 records as of October 2006 |
| Update Frequency: | Weekly |
|
IMS R&D Focus is produced by IMS Health. Questions concerning file content should be addressed to: Customer Services Dept., Global Services 7 Harewood Avenue London, NW1 6JB England
|
For Dialog's Redistribution and Archive Policy, enter HELP ERA online. The following terms and conditions also apply.
These databases are copyrighted by IMSworld Publications. No part of these databases may be copied or duplicated in hard copy or machine-readable form without prior written permission of IMSworld Publications.
If data is to be distributed under Dialog's Redistribution policy, distribution is restricted to within the geographic boundaries of the country where the data was first downloaded. Under NO CIRCUMSTANCES may data which has been downloaded, distributed, or copied under this provision be sold or resold to a third party outside the user's company organization.
